ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESI....FIRO..CY..TRBGCZEEHU..SK....................................*JJDIM360 Ver 1.28 (29 Oct 2014) - 2999001/0201610141594433CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120161221W173deBibliographieenBibliographyfrBibliographieEP04702173.8200401142005080520100910enenen440009 P20030114US2016122120165120051116200546201601132016022015072020160131BE20160113NL20160414GR20160113FI20160113AT20160513PT20160113SE20160131CH20160131LI20160113DK20160113MC20160113EE20160113SK20160113RO20160113CZ20161221201651A61K 38/39 20060101AFI20150527BHEP A61K 31/00 20060101ALI20150527BHEP A61K 45/06 20060101ALI20150527BHEP A61K 38/17 20060101ALI20150527BHEP A61P 35/00 20060101ALI20150527BHEP A61K 31/513 20060101ALI20150527BHEP A61K 31/4745 20060101ALI20150527BHEP A61K 31/7048 20060101ALI20150527BHEP A61K 33/24 20060101ALI20150527BHEP deSENSIBILISATOR FÜR KREBSTHERAPIEenCANCER THERAPY SENSITIZERfrSENSIBILISANT D'UNE THERAPIE DE CANCERWO-A-02/089772US-A1- 2003 082 228US-B1- 6 406 693US-B1- 6 475 784G.K. YIU ET AL: "SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis in Ovarian Cancer Cells" AMERICAN JOURNAL OF PATHOLOGY, vol. 159, no. 2, February 2001 (2001-02), pages 609-622, XP002983766I.A. CREE ET AL: "Chemosensitization of Solid Tumor Cells by Alteration of their Susceptibility to Apoptosis" CURRENT OPINION IN INVESTIGATIONAL DRUGS, vol. 3, no. 4, April 2002 (2002-04), pages 641-647, XP008095641N. DHANESUAN ET AL: "Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition." BREAST CANCER RESEARCH, vol. 75, no. 1, September 2002 (2002-09), pages 73-85, XP002493062U. STEIN ET AL: "Reversal of Multidrug Resistance by Transduction of Cytokine Genes into Human Colon Carcinoma Cells" JOURNAL OF THE NATIONAL CANCER INSTITUTE, vol. 88, no. 19, 2 October 1996 (1996-10-02), pages 1383-1392, XP002493063YIU G.K. ET AL: 'SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis in Ovarian Cancer Cells' AM J PATHOL vol. 159, no. 2, August 2001, pages 609 - 662, XP002983766CHLENSKI A. ET AL: 'SPARC Is a Key Schwannian-derived Inhibitor Controlling Neuroblastoma Tumor Angiogenesis' CANCER RES vol. 62, 15 December 2002, pages 7357 - 7363, XP0029869162008090212183770.2256188720120910TAI, Isabelle, T.2502-1408 Strathmore Mews N.Vancouver, B.C. V6Z 3A9CACHEN, Lan, Bo184 E. Emerson RoadLexington, MA 02420USDana-Farber Cancer Institute, Inc.101238798P023631EP RCD450 Brookline AvenueBoston, MA 02115-5450USD Young & Co LLP101533551120 HolbornLondon EC1N 2DYGBATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEITLILUMCNLPTROSESISKTRUS200400090120040114enWO200406478520040805200432